Arginine–Pectin Gummy Composition for Stable Anti-Caries Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing oral care products face challenges in formulating compositions containing basic amino acids like arginine with pectin due to polymer aggregation and degradation of pectin networks, leading to instability and inefficiency in manufacturing chewable products that provide anti-caries benefits.
Innovation Solution
A stable chewable composition comprising arginine and pectin, with specific ratios and amounts, that effectively transports arginine to the teeth to inhibit cariogenic bacteria and promote arginolytic bacteria, thereby preventing caries.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If basic amino acids (arginine) are incorporated into pectin-based chewable compositions, then anti-caries benefits and bacterial modulation effects are achieved, but polymer aggregation and pectin network degradation occur leading to formulation instability
Solution Approach 1:
The patent applies parameter changes by carefully controlling the ratio of basic amino acids to acidic gelling agents (specifically maintaining arginine at 0.1-5% w/w and pectin at 0.1-10% w/w with specific ratios between them), adjusting pH levels, and controlling molecular weights to prevent polymer aggregation while maintaining pectin network stability and anti-caries efficacy
Solution Approach 2:
The patent creates a composite material system by combining basic amino acids (arginine) with acidic gelling agents (pectin, xanthan gum, gellan gum) in specific formulations that leverage the functional benefits of both components while mitigating their adverse interactions through careful formulation design
2Reliability
If basic amino acids are used in chewable oral care products, then cariogenic bacteria are inhibited and arginolytic bacteria are promoted, but manufacturing efficiency decreases due to formulation difficulties
Solution Approach 1:
The patent optimizes manufacturing efficiency by establishing specific parameter ranges for ingredient concentrations (arginine 0.1-5% w/w, pectin 0.1-10% w/w), pH levels, and molecular weights that ensure formulation stability while maintaining ease of manufacture and consistent oral health benefits
Solution Approach 2:
The patent uses acidic gelling agents as intermediaries that facilitate the incorporation of basic amino acids into stable chewable formulations, enabling efficient manufacturing while preserving the anti-caries functionality of arginine
3Quantity of substance
If basic amino acids interact with pectin chains, then specific interactions occur that reduce effective charge, but this reduces the ability of pectin to form stable pectin networks
Solution Approach 1:
The patent resolves the charge interaction issue by controlling the pH of the formulation and selecting pectin with specific molecular weights and degree of esterification, which maintains sufficient effective charge on pectin chains for stable network formation while preserving amino acid availability for bacterial modulation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition significantly reduces S. mutans in oral biofilms and increases S. gordonii to S. mutans ratio, enhancing anti-caries effects and promoting tooth remineralization.
Implementation Method 1
The arginolytic bacteria can use arginine and other basic amino acids to produce ammonia, thereby raising the pH of their environment
Implementation Method 2
cariogenic bacteria metabolize sugar to produce lactic acid, which tends to lower the plaque pH and demineralize the teeth
Implementation Method 3
the formulation of compositions containing basic amino acids into a pectin base may lead to polymer aggregation as the basic amino acids have the potential to act as non-covalent crosslinking agents in pectin networks
Data Source
AI summary
Disclosed herein are oral compositions comprising an amino acid and a gelling agent. In certain embodiments, the chewable composition is in the form of a gummy comprising arginine and pectin. Related kits and methods of use are further provided.